TABLE 2.
Participant's characteristics study B; effects of 7 day use of JD on blood pressure and DN position
| Subject No | Gender | Age Range (years) | BMI (Kg/mt2) | BMI Status | HTN Status | Medications |
|---|---|---|---|---|---|---|
| 1 | F | 35–45 | 32.3 | OB | NL | |
| 2 | F | 35–45 | 20.9 | NL | NL | |
| 3 | M | 60–70 | 30.7 | OB | HNL | |
| 4 | F | 75–85 | 31.1 | OB | G 1 | Atenolol/Amlodipine |
| 5 | M | 60–70 | 32.1 | OB | G 2 | Atenolol |
| 6 | F | 60–70 | 29.6 | OV | HNL | Lisinopril/Insulin |
| 7 | M | 50–60 | 29.3 | OV | G 2 | |
| 8 | F | 60–70 | 23.2 | NL | G 2 | |
| 9 | F | 60–70 | 28.9 | OV | G 2 | |
| 10 | M | 55–65 | 25.8 | OV | NL | |
| 11 | M | 60–65 | 28.9 | OV | G 1 | |
| 12 | M | 30–35 | 27.5 | OV | NL | |
| 13 | F | 50–55 | 31.8 | OB | G 1 | |
| 14 | F | 30–35 | 18.5 | NL | HNL | |
| 15 | F | 25–30 | 22.9 | NL | NL | |
| 16 | M | 30–35 | 20.3 | NL | G 1 | |
| 17 | F | 25–30 | 28.2 | OV | HNL | Lisinopril/Metformin |
| 18 | M | 60–65 | 29.6 | OV | G 1 | |
| 19 | F | 40–45 | 25.4 | OV | G1 | |
| 20 | F | 45–50 | 26.7 | OV | G1 | |
| Mean ± SD | 52.2 ± 17 | 27.2 ± 4 | 8 = OB, 5 = NL, 7 = OV |
4 = NL, 4 = HNL, 7 = G1, 5 = G 2 |
Notes: Characteristics of the participant for study B; sex (M = male, F = female), age range in years, body mass index (BMI), BMI Status; BMI normal weight BMI 18.5–24.9 (NL), overweight 25–22.9 (OV) and obese 30 or more (OB). The initial blood pressure status (HTN) at the beginning of the study was classified according to the 2021 European guidelines (Stergiou et al., 2021) Normal optimal BP (NL < 130/85 mmHg), High‐normal BP (HNL, 130–139/85–89 mmHg), Hypertension grade 1 (G1,140–159/90–99 mmHg), Hypertension grade 2 and 3 (G2‐3, ≥160/100 mmHg) and medications used at the time of enrollment.